Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08ILW
|
||||
| Former ID |
DNC014089
|
||||
| Drug Name |
Cyclohexyl biphenyl-4-ylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529975] | ||
| Formula |
C19H21NO2
|
||||
| Canonical SMILES |
C1CCC(CC1)OC(=O)NC2=CC=C(C=C2)C3=CC=CC=C3
|
||||
| InChI |
1S/C19H21NO2/c21-19(22-18-9-5-2-6-10-18)20-17-13-11-16(12-14-17)15-7-3-1-4-8-15/h1,3-4,7-8,11-14,18H,2,5-6,9-10H2,(H,20,21)
|
||||
| InChIKey |
SSVRRVRYQFRADL-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529975] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.